Kalyan Jewellers stock: Q2 profit seen up 30% despite margin risk
HPSP stock slips 8.23% as November results approach
Hengrui Medicine stock: FDA accepts camrelizumab filing
Doosan Enerbility stock advances on new NuScale SMR contract
Doosan Robotics stock pivots toward auto and chip plants
Canara Bank stock in focus after November deposit-rate changes
Gulf Energy Stock: Q3 Profit Rose 28% to THB 9.289 Billion
Federal Bank stock draws focus after record Q2 profit of INR 1,386 crore
Sterling Infrastructure stock enters Friday after late-session quote
The Office Is Being Reinvented — Just Don't Expect the Furniture to Fix Your Aching Shoulders
Vertiv's Order Book Is the Only Answer That Matters Now
Ingenia Communities stock: Board rejects amended Warburg bid
Raizen stock faces split as shareholders back restructuring
ICTSI stock defends Durban Pier 2 deal against Maersk challenge
Service Corporation International stock faces lower 2026 outlook
Yarrow Bioscience stock: Three November investor events ahead
Tutor Perini stock: Record Q3 results lift 2026 EPS guidance
ACC stock advances cement expansion as Ambuja merger moves ahead
Formosa Plastics stock faces Texas supply risk after shutdown
HPCL stock: Q2 profit returns as refining margins surge
Tyson Foods stock trades at 53.61 euros as brands span protein foods
JG Summit stock plans 37.1 billion-share Oriental Petroleum transfer
Target Hospitality stock: Q3 report scheduled for November 9
Elang Mahkota Technology stock: Emtek exits Indopay control
Veracyte stock trades at EUR 21.32 late Thursday
Genting Singapore stock target cut as tourism outlook dims
YDUQS stock: Afya merger heads to November 25 vote
Kolon Industries stock slips in late South Korean trading
Terex stock: Q3 sales rise as board approves USD 500 million buyback
BTS Group Holdings stock: Q1 revenue reaches THB 7.49 billion
Source Energy Services stock faces pressure after 5% slide
Tennant stock posts 6.2% Q3 sales growth as robotics accelerates
Ralph Lauren stock rises after earnings beat and outlook lift
Centuria stock: UBS cuts target to AU$1.72, keeps Buy rating
Arcus Biosciences stock trades at 17.69 US dollars after-hours